IAM helps Allergan move to Open Science
Allergan, maker of Botox and one of the first companies to call itself "growth pharma," fosters an Open Science culture, partnering with independent researchers and positioning itself as "a magnet for game-changing ideas and innovation." Trust is critical for building relationships with doctors and patients, as well as for developing relationships with business or acquisition partners. As a pharmaceutical, the company must also stay in strict compliance with government regulations, such as HIPAA, FDA rules, and the Sunshine Act, in addition to Sarbanes-Oxley.
Identity and access management play an increasingly important role as the Allergan IT team works to establish a consistent process for integrating its constantly shifting digital environment. Initially, the challenge was to move from a confusing mix of IAM providers to a single, foundational partner.